Evidence map›Paper›PMID 35050413›Full record

ArticlePlanta2022

Minc03328 effector gene downregulation severely affects Meloidogyne incognita parasitism in transgenic Arabidopsis thaliana.

Valdeir Junio Vaz Moreira, Isabela Tristan Lourenço-Tessutti, Marcos Fernando Basso, Maria Eugênia Lisei-de-Sa, Carolina Vianna Morgante, Bruno Paes-de-Melo, Fabrício Barbosa Monteiro Arraes, Diogo Martins-de-Sa, Maria Cristina Mattar Silva, Janice de Almeida Engler and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Planta, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Valdeir Junio Vaz MoreiraEmbrapa Genetic Resources and Biotechnology, Brasilia, DF, 70770-917, Brazil.
Isabela Tristan Lourenço-TessuttiEmbrapa Genetic Resources and Biotechnology, Brasilia, DF, 70770-917, Brazil.
Marcos Fernando BassoEmbrapa Genetic Resources and Biotechnology, Brasilia, DF, 70770-917, Brazil.ORCID http://orcid.org/0000-0001-8192-8959
Maria Eugênia Lisei-de-SaEmbrapa Genetic Resources and Biotechnology, Brasilia, DF, 70770-917, Brazil.
Carolina Vianna MorganteEmbrapa Genetic Resources and Biotechnology, Brasilia, DF, 70770-917, Brazil.
Bruno Paes-de-MeloEmbrapa Genetic Resources and Biotechnology, Brasilia, DF, 70770-917, Brazil.
Fabrício Barbosa Monteiro ArraesEmbrapa Genetic Resources and Biotechnology, Brasilia, DF, 70770-917, Brazil.
Diogo Martins-de-SaEmbrapa Genetic Resources and Biotechnology, Brasilia, DF, 70770-917, Brazil.
Maria Cristina Mattar SilvaEmbrapa Genetic Resources and Biotechnology, Brasilia, DF, 70770-917, Brazil.
Janice de Almeida EnglerNational Institute of Science and Technology, INCT PlantStress Biotech, Embrapa, 70297-400, Brazil.
Maria Fatima Grossi-de-SaEmbrapa Genetic Resources and Biotechnology, Brasilia, DF, 70770-917, Brazil. fatima.grossi@embrapa.br.
Brazilian Agricultural Research Corporation · BRUniversidade de Brasília · BRUniversidade Federal do Rio Grande do Sul · BRCentre National de la Recherche Scientifique · FRUniversidade Federal de Viçosa · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MAIN

conclusionMinc03328 effector gene downregulation triggered by in planta RNAi strategy strongly reduced plant susceptibility to Meloidogyne incognita and suggests that Minc03328 gene is a promising target for the development of genetically engineered crops to improve plant tolerance to M. incognita. Meloidogyne incognita is the most economically important species of root-knot nematodes (RKN) and causes severe damage to crops worldwide. M. incognita secretes several effector proteins to suppress the host plant defense response, and manipulate the plant cell cycle and other plant processes facilitating its parasitism. Different secreted effector proteins have already been identified in M. incognita, but not all have been characterized or have had the confirmation of their involvement in nematode parasitism in their host plants. Herein, we characterized the Minc03328 (Minc3s00020g01299) effector gene, confirmed its higher expression in the early stages of M. incognita parasitism in plants, as well as the accumulation of the Minc03328 effector protein in subventral glands and its secretion. We also discuss the potential for simultaneous downregulation of its paralogue Minc3s00083g03984 gene. Using the in planta RNA interference strategy, Arabidopsis thaliana plants overexpressing double-stranded RNA (dsRNA) were generated to specifically targeting and downregulating the Minc03328 gene during nematode parasitism. Transgenic Minc03328-dsRNA lines that significantly downregulated Minc03328 gene expression during M. incognita parasitism were significantly less susceptible. The number of galls, egg masses, and [galls/egg masses] ratio were reduced in these transgenic lines by up to 85%, 90%, and 87%, respectively. Transgenic Minc03328-dsRNA lines showed the presence of fewer and smaller galls, indicating that parasitism was hindered. Overall, data herein strongly suggest that Minc03328 effector protein is important for M. incognita parasitism establishment. As well, the in planta Minc03328-dsRNA strategy demonstrated high biotechnological potential for developing crop species that could efficiently control RKN in the field.

Indexed as

ArabidopsisTylenchoideaAnimalsDown-RegulationPlant DiseasesPlant RootsCrop protectionEffector proteinIn planta RNAiNew biotechnological toolsPlant–nematode interactionRoot-knot nematode

Identifiers

PMID35050413
OpenAlexW4206654543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.